Results 141 to 150 of about 2,262 (198)

Exploring evolutionary trajectories of drug resistance. [PDF]

Proc Natl Acad Sci U S A
Hu L, Zhang A, Warshel A.
europepmc   +1 more source

Sofosbuvir/Velpatasvir in Chronic Hepatitis C, Compensated and Decompensated Cirrhosis, and Retreatment Settings. [PDF]

Intern Med
Takada H, Tamaki N, Ochi H, Mori N, Tsuji K, Tada T, Nakamura S, Toshimori J, Yoshioka N, Arai H, Fujii H, Hasebe C, Murohisa T, Okamoto E, Kondo M, Marusawa H, Urawa N, Yoshioka T, Yoshida H, Narita R, Akahane T, Kusakabe A, Nonogi M, Imado R, Uchida Y, Sato T, Yokohama K, Kubotsu Y, Ishii T, Izumi N, Kurosaki M.   +30 more
europepmc   +1 more source

Virtual Screening-Guided Identification of Candidate USP7-Inhibitory Scaffolds Exhibiting Antiproliferative Activity. [PDF]

Pharmaceuticals (Basel)
Oliveira RI, Franco C, Mano M, Leal AS, Salvador JAR.   +4 more
europepmc   +1 more source

Retrospective Study of Risk Factors Associated with Hepatic Dysfunction Induced by Daclatasvir/Asunaprevir

, 2018
Naoki Yoshikawa, Kazuhiro Kitahata, Manabu Okumura, Tomomi Iwakiri, Hiroshi Sekiya, Kazuhiko Arimori, Yuko Yonezawa, Yasuji Arimura, Ryuji Ikeda   +8 more
openalex   +2 more sources

A novel scoring system to identify patients at low risk for hepatocellular carcinoma five years after DAA-Induced sustained virological response: a retrospective cohort study. [PDF]

BMC Gastroenterol
Fujii H, Nishimura T, Kimura H, Mitsumoto Y, Shima T, Seko Y, Moriguchi M, Kataoka S, Tanaka S, Ishikawa H, Takami S, Nagao Y, Umemura A, Itoh Y, Yamaguchi K.   +14 more
europepmc   +1 more source

Successful retreatment with sofosbuvir plus ledipasvir for cirrhotic patients with hepatitis C virus genotype 1b, who discontinued the prior treatment with asunaprevir plus daclatasvir: A case series and review of the literature

, 2017
Yuki Haga, Tatsuo Kanda, Shin Yasui, Masato Nakamura, Yoshihiko Ooka, Koji Takahashi, Shuang Wu, Shingo Nakamoto, Makoto Arai, Tetsuhiro Chiba, Hitoshi Maruyama, Osamu Yokosuka, Nobuo Takada, Mitsuhiko Moriyama, Fumio Imazeki, Naoya Kato   +15 more
openalex   +2 more sources

Comparative analysis of phytocompounds and repurposed drugs against dengue virus serotypes employing an in silico study. [PDF]

Sci Rep
Vats P, Rolta R, Salaria D, Sharma I, Verma A, Fadare OA, Verma M.   +6 more
europepmc   +1 more source

Late Relapse after a Sustained Virologic Response at 24 Weeks after Treatment with Daclatasvir and Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b Infection with Liver Cirrhosis

, 2017
Haruki Uojima, Shuko Murakami, Seigo Nakatani, Hisashi Hidaka, Atsuko Takeuchi, Yoshiaki Tanaka, Tomoyoshi Inoue, Keiko Yamane, Kousuke Kubota, Takahide Nakazawa, Akitaka Shibuya, Yasuhito Tanaka, Wasaburo Koizumi   +12 more
openalex   +2 more sources

Hepatitis C Virus Resistance-Associated Substitutions in Mexico. [PDF]

Viruses
Jose-Abrego A, Laguna-Meraz S, Roman S, Mariscal-Martinez IM, Panduro A.   +4 more
europepmc   +1 more source

HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients

, 2017
Laëtitia Canini, Michio Imamura, Yoshiiku Kawakami, Susan L. Uprichard, Scott J. Cotler, Harel Dahari, Kazuaki Chayama   +6 more
openalex   +2 more sources